By Asian News International | Posted by Shivani Kale | Washington
UPDATED ON DEC 24, 2020 05:20 PM IST
Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of Covid-19 following SARS-CoV-2 infection.
By Agencies | Singapore
PUBLISHED ON NOV 30, 2020 01:36 AM IST
The baby was born this month without Covid-19 but with the virus antibodies, the Straits Times newspaper reported on Sunday, citing the mother.
Antibodies from patients infected with SARS-CoV in 2003 cross-neutralised SARS-CoV-2 in vitro: Study
By Asian News International| Posted by Susmita Pakrasi | Washington
UPDATED ON OCT 10, 2020 02:15 PM IST
The authors also report that, surprisingly, mice and rabbits immunised with a receptor-binding domain (RBD) from a strain of SARS-CoV that infects the Himalayan palm civet elicited stronger antibody responses against SARS-CoV-2 than animals immunised with an RBD from a human SARS-CoV strain.
By Press Trust of India| Posted by Susmita Pakrasi | New York
UPDATED ON OCT 09, 2020 03:27 PM IST
The scientists focused only on antibodies specific to the receptor binding domain of the SARS-CoV-2 spike protein which it uses to enter host cells.
By Press Trust of India | Posted by Zarafshan Shiraz | New Delhi
UPDATED ON SEP 05, 2020 10:11 AM IST
Indian researchers understand coronavirus infection recovery and re-infection pattern better after study reveals that anti SARS-CoV-2 antibodies could remain for more than 60 days in the body
By Sweta Goswami and Abhishek Dey | Hindustan Times, New Delhi
UPDATED ON AUG 20, 2020 03:42 PM IST
The findings of the second survey show that the prevalence of antibodies among the people has increased by over 6 percentage points when compared to the first survey held between June 27 and July 10
By Narinder Kumar Mehra
UPDATED ON JUL 23, 2020 06:27 PM IST
Studies have explained immunity to Covid-19, but there’s no clarity on the grades of immune responses of people
By Press Trust of India | Singapore
PUBLISHED ON JUN 17, 2020 02:23 PM IST
Human trials for the lead antibody, AOD01, will commence in the coming months, pending approval from the Health Sciences Authority, said the Defense Science Organisation (DSO) National Laboratories.
By Press Trust of India | Beijing
PUBLISHED ON MAY 14, 2020 02:02 PM IST
The antibodies identified by the researchers, including those from Chinese Academy of Sciences, bind to the glycoprotein spike of the SARS-CoV-2 virus, blocking the spike’s ability to bind to the human ACE2 receptor and mediate viral entry into host cells.
By Reuters | Geneva
PUBLISHED ON APR 18, 2020 09:38 AM IST
Mike Ryan, the WHO’s top emergencies expert, also said that even if antibodies were effective there was little sign that large numbers of people had developed them and were beginning to offer so-called “herd immunity” to the broader population.